ATNC-MDD V1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATNC-MDD V1, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia [NA]